While the mechanism of CRHR signaling in urothelial cells is still unclear, the changes in the receptor expression suggest that CRH-related peptides could play a role in the IC/BPS etiopathology. This evidence concerns the gene CRHR1 and Bartsocas-Papas syndrome 1.